Sale!

TAC3 Gene Hypogonadotropic Hypogonadism Type 10 with or without Anosmia NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The TAC3 Gene Hypogonadotropic Hypogonadism Type 10 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the TAC3 gene responsible for hypogonadotropic hypogonadism type 10, a rare endocrine disorder affecting puberty and reproductive development. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that disrupt normal gonadotropin-releasing hormone signaling, leading to delayed or absent puberty and potential anosmia (loss of smell). The test provides crucial diagnostic information for individuals experiencing delayed sexual development, infertility, or reproductive hormone imbalances. With results available in 3-4 weeks from blood or DNA samples, this $500 USD test offers definitive genetic confirmation and enables targeted treatment planning. Genetic counseling is included to help patients understand their results and inheritance patterns.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

TAC3 Gene Hypogonadotropic Hypogonadism Type 10 with or without Anosmia NGS Genetic DNA Test

Understanding TAC3 Gene Hypogonadotropic Hypogonadism Type 10

Hypogonadotropic hypogonadism type 10 is a rare genetic endocrine disorder characterized by impaired production or action of gonadotropin-releasing hormone (GnRH), which is essential for normal puberty and reproductive function. The TAC3 gene encodes neurokinin B, a crucial neuropeptide involved in the regulation of GnRH secretion from the hypothalamus. Mutations in this gene disrupt the complex neuroendocrine signaling cascade necessary for proper sexual development and reproductive hormone production.

What This Test Measures and Detects

Our advanced NGS Genetic DNA Test specifically analyzes the TAC3 gene to identify pathogenic variants associated with hypogonadotropic hypogonadism type 10. The test detects:

  • Point mutations, insertions, and deletions in the TAC3 gene coding regions
  • Variants affecting neurokinin B production and function
  • Genetic changes that disrupt GnRH pulse generator activity
  • Mutations leading to impaired kisspeptin-neurokinin B-dynorphin neuronal signaling
  • Both autosomal recessive inheritance patterns

Who Should Consider This Test

This genetic test is recommended for individuals presenting with:

  • Delayed or absent puberty beyond age 14 in females and 15 in males
  • Primary amenorrhea in females
  • Micropenis or cryptorchidism in males
  • Infertility with low gonadotropin levels
  • Anosmia or hyposmia (complete or partial loss of smell)
  • Family history of delayed puberty or reproductive disorders
  • Unexplained hypogonadism with normal pituitary imaging
  • Consanguineous family background with reproductive issues

Clinical Benefits of Genetic Testing

Undergoing TAC3 gene testing provides numerous clinical advantages:

  • Definitive Diagnosis: Confirms genetic etiology of hypogonadotropic hypogonadism
  • Personalized Treatment: Guides appropriate hormone replacement therapy
  • Reproductive Planning: Informs fertility treatment options and timing
  • Family Risk Assessment: Identifies carrier status and inheritance patterns
  • Prognostic Information: Helps predict treatment response and long-term outcomes
  • Differential Diagnosis: Distinguishes from other forms of hypogonadism
  • Psychological Relief: Provides explanation for developmental concerns

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and endocrinologists:

  • Positive Result: Identifies pathogenic TAC3 gene mutation confirming diagnosis of hypogonadotropic hypogonadism type 10
  • Negative Result: No mutation detected in TAC3 gene, suggesting alternative causes for symptoms
  • Variant of Uncertain Significance: Identifies genetic change with unclear clinical impact requiring further evaluation
  • Carrier Status: Identifies individuals with one mutated copy who may pass the condition to offspring

All results include comprehensive genetic counseling to ensure complete understanding and appropriate next steps for management and family planning.

Test Pricing and Details

Test Feature Details
Test Name TAC3 Gene Hypogonadotropic Hypogonadism Type 10 with or without Anosmia NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before testing, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to create detailed family pedigree
  • Documentation of symptoms and previous endocrine evaluations
  • Informed consent for genetic testing

Nationwide Testing Availability

We have convenient testing locations across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing centers ensures accessible, reliable service regardless of your location.

Take Control of Your Reproductive Health

Don’t let uncertainty about your reproductive development or family planning decisions cause unnecessary stress. Our TAC3 Gene Hypogonadotropic Hypogonadism Type 10 NGS Genetic DNA Test provides the clarity and answers you need to make informed healthcare decisions. With our discounted price of $500 USD and comprehensive genetic counseling support, you can gain valuable insights into your genetic health.

Ready to schedule your genetic test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment or speak with our genetic counseling team. Take the first step toward understanding your reproductive health and planning your future with confidence.